These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3782093)

  • 1. Identification of two sites of sulfation of human heparin cofactor II.
    Hortin G; Tollefsen DM; Strauss AW
    J Biol Chem; 1986 Dec; 261(34):15827-30. PubMed ID: 3782093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
    Van Deerlin VM; Tollefsen DM
    J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the site of sulfation of the fourth component of human complement.
    Hortin G; Sims H; Strauss AW
    J Biol Chem; 1986 Feb; 261(4):1786-93. PubMed ID: 3944109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfation of a tyrosine residue in the plasmin-binding domain of alpha 2-antiplasmin.
    Hortin G; Fok KF; Toren PC; Strauss AW
    J Biol Chem; 1987 Mar; 262(7):3082-5. PubMed ID: 2434496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
    Mitchell JW; Church FC
    J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III.
    Griffith MJ; Noyes CM; Church FC
    J Biol Chem; 1985 Feb; 260(4):2218-25. PubMed ID: 3838304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
    Preissner KT; Sié P
    Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.
    Pittman DD; Wang JH; Kaufman RJ
    Biochemistry; 1992 Apr; 31(13):3315-25. PubMed ID: 1554716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine sulfation and N-glycosylation of human heparin cofactor II from plasma and recombinant Chinese hamster ovary cells and their effects on heparin binding.
    Böhme C; Nimtz M; Grabenhorst E; Conradt HS; Strathmann A; Ragg H
    Eur J Biochem; 2002 Feb; 269(3):977-88. PubMed ID: 11846800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
    Maimone MM; Tollefsen DM
    J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A
    Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte chemoattractant peptides from the serpin heparin cofactor II.
    Church FC; Pratt CW; Hoffman M
    J Biol Chem; 1991 Jan; 266(2):704-9. PubMed ID: 1985958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells.
    Tornqvist HE; Gunsalus JR; Nemenoff RA; Frackelton AR; Pierce MW; Avruch J
    J Biol Chem; 1988 Jan; 263(1):350-9. PubMed ID: 3275643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a unique sequence in heparin for interaction with heparin cofactor II? Structural and biological studies of heparin-derived oligosaccharides.
    Petitou M; Lormeau JC; Perly B; Berthault P; Bossennec V; Sié P; Choay J
    J Biol Chem; 1988 Jun; 263(18):8685-90. PubMed ID: 3379040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of chymotrypsin by heparin cofactor II.
    Church FC; Noyes CM; Griffith MJ
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6431-4. PubMed ID: 3863104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
    Abildgaard U; Larsen ML
    Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of heparin cofactor II by heparin and dermatan sulfate.
    Tollefsen DM
    Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for essential lysines in heparin cofactor II.
    Church FC; Griffith MJ
    Biochem Biophys Res Commun; 1984 Nov; 124(3):745-51. PubMed ID: 6439196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.